academic article

• Estimated number and percentage of US adults with atherosclerotic cardiovascular disease recommended add-on lipid-lowering therapy by the 2018 AHA/ACC multi-society cholesterol guideline..  American heart journal plus : cardiology research and practice.  2022
• Lipoprotein(a) and the Risk for Coronary Heart Disease and Ischemic Stroke Events Among Black and White Adults With Cardiovascular Disease..  Journal of the American Heart Association.  11:-. 2022
• Low-density lipoprotein cholesterol levels among individuals experiencing statin-associated symptoms: Data from the REasons for Geographic And Racial Differences in Stroke (REGARDS) study..  Journal of clinical lipidology.  14:720-729. 2020
• Characteristics and Cardiovascular Disease Event Rates among African Americans and Whites Who Meet the Further Cardiovascular Outcomes Research with PCSK9 Inhibition in Subjects with Elevated Risk (FOURIER) Trial Inclusion Criteria..  Cardiovascular drugs and therapy.  33:189-199. 2019
• Willingness to be Reinitiated on a Statin (from the REasons for Geographic and Racial Differences in Stroke Study)..  The American journal of cardiology.  122:768-774. 2018
• PCSK9 Variants, Low-Density Lipoprotein Cholesterol, and Neurocognitive Impairment: Reasons for Geographic and Racial Differences in Stroke Study (REGARDS)..  Circulation.  137:1260-1269. 2017
• PCSK9.  Circulation. Cardiovascular genetics.  10:-. 2017
• Association of Serum Lipids and Coronary Heart Disease in Contemporary Observational Studies..  Circulation.  133:256-64. 2015